The most recent clinical level research across Australasian region were focused on the usage of adjuvants in the treatment of gastrointestinal stromal tumors, usage of imatinib, ibrutinib and BTK inhibitor in cases of lymphoma and laproscopy techniques for rectal neoplasms. Over the past few years, the incidence of cancer including gastrointestinal tumors and the rectal cancer has become emerging public health concern particularly among the working age adults in countries of Australia and New Zealand. The incidence of cancer types associated with the gastrointestinal track are due to higher level of alcohol consumption, intake of red meat and processed meat and higher incidence of obesity. The treatment of these form of cancers are often invasive and could potentially affect their employment by way of reduced working hours and earning and discontinuation of other socio-economic activities. These ramifications lead to financial burden and psychological stress for cancer survivors affecting not only the quality of life but also their economic security.